ZOLEDRONATE INFUSION EVERY 1.5 YEARS REDUCES FRACTURES: Level 1 [likely reliable] evidence

Osteopenia places postmenopausal women at a higher risk for fragility fracture, which can increase morbidity and mortality. To date, no randomized trial has demonstrated therapeutic benefit of bisphosphonate therapy for [...]